Outlook Aims To Remedy FDA Concerns On Ophthalmic Bevacizumab

Requests Type A Meeting With FDA Following Complete Response Letter

 
• By David Wallace
Eye data binary
Outlook is looking to resolve issues with its BLA • Source: Shutterstock

More from Biosimilars

More from Products